EconPapers    
Economics at your fingertips  
 

Seminar Briefings

From Office of Health Economics
Contact information at EDIRC.

Bibliographic data for series maintained by Publications Manager ().

Access Statistics for this working paper series.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.


001942: NHS Agency Staffing and the Impact of Recent Interventions
C. Mullin
001880: Interventions that Encourage High-value Nursing Home Care: Lessons for the UK
D. Grabowski
001804: Delivering an Outcomes-based NHS: Creating the Right Conditions
N. Hicks
001724: Waiting Time Policies in the Health Sector
L. Siciliani
001653: Multi-indication Pricing: Pros, Cons and Applicability to the UK
J. Mestre-Ferrandiz, A. Towse, R. Dellamano and M. Pistollato
001616: Improving the Fiscal and Political Sustainability of Health Systems through Integrated Population Needs-Based Planning
S. Birch
001589: A Framework for Payer Assessment of the Value of New Technologies: A US Approach
S. Pearson
001556: Biosimilar Competition: Lessons from Europe and Prospects for the US
H. Grabowski
000482: Mental Health Economics and Policy in a Global Context
J. Sussex
000478: Making the best of the Private Finance Initiative in the NHS
J. Sussex
000454: The New NHS: What Can We Learn From Managed Care in New Zealand and the US?
N. ed Goodwin
000451: Public Involvement in Priority Setting
L. ed Gold
000449: Leadership, Change and Primary Care Groups
L. ed Locock
000219: Innovation in Medicines: Can We Value Progress?
J. Sussex
000197: Science Policy Research: Having an Impact on Policy?
B. Martin
000193: Priority Review Vouchers to Encourage Innovation for Neglected Diseases
H.g Grabowski
000174: Summary Report of the OHE/EFPIA Antibacterial Roundtable
P. Sharma
000173: Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?
C. Donaldson
000146: Is There a Productivity Crisis in Pharmaceutical R&D?
M. Riccaboni
000141: Value Based Pricing in Sweden: Lessons for Design?
U. Persson
000077: Real Option Value and Path Dependence in Oncology Innovation
J.p Cook
000074: Can the US Afford to Ignore Cost-effectiveness Evidence?
J. Chambers
Page updated 2018-04-19
Sorted by numeric handle